April 14, 2017 Health & Science
“[Funding received] represents a significant step towards commercialization of our LaparoGuard technology,” said Mitch Wilson, President & COO of Mariner Endosurgery. “Mariner’s computer-assisted platform provides augmented visualization for surgeons during minimally invasive general, gynecological and urological surgical procedures.”
Mariner Endosurgery develops and commercializes innovative computer assisted medical devices for future-facing laparoscopic surgeries. Their platform LaparoGuard is a novel soft-tissue surgical navigation platform that augments visualization during laparoscopic surgeries, enhancing the safety profile of laparoscopic surgery to assist surgeons in delivering a superior quality of care to their patients.
The OBIO Capital Access Advisory Program operates downstream from existing entrepreneurship programs and targets the critical issue of access to capital at a post-seed stage of venture financing. OBIO CAAP strengthens Ontario’s cadre of investable human health technology companies, increasing high value deal flow.
Congratulations to the Mariner Endosurgery team!